Orthopediatrics Corp (KIDS)

Featured in Small-Cap Stocks

OrthoPediatrics Corp. is a medical device company focused on orthopedic solutions for children with musculoskeletal conditions. The company designs, develops, and markets anatomically appropriate implants, surgical instruments, and specialized braces for pediatric patients in the United States and international markets. Its product range spans trauma and deformity correction, scoliosis treatment, and sports medicine applications. Key offerings include systems and devices such as PediLoc, PediPlates, PediNail, RESPONSE Spine, Orthex, the Fassier-Duval Telescopic Intramedullary System, ApiFix Mid-C System, and Boston Brace 3D. OrthoPediatrics also serves pediatric orthopedic surgeons and caregivers. Founded in 2006, the company is headquartered in Warsaw, Indiana. The listed security is common stock on NASDAQ under the ticker KIDS.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-KIDS
$20.17
3.5% Upside
Fair
$25
28.2% Upside
Undervalued
Good
0.0%
August 5, 2026
-12.6x
1.5x
2.1x
501.4 M
565 M
18.3%
66.5%
1.8
31.8%
Valuation • Fair Value

Orthopediatrics Corp (NASDAQ-KIDS) Fair Value by Valuation Model

Compare the primary fair value estimate for Orthopediatrics Corp (NASDAQ-KIDS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$20.17

Estimated upside of 3.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$19.89

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$12.71

Earnings power value estimate.

Comps Fair Value

$21.70

Comparable-company valuation reference.

Analyst Price Target

$25

Analysts imply upside of 28.2%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Orthopediatrics Corp (NASDAQ-KIDS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Orthopediatrics Corp (NASDAQ-KIDS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

243.3 M

Current operating scale indicator.

Revenue Forecast

265 M

Forward revenue estimate.

EBITDA

-4.601 M

Current operating profitability reference.

EBITDA Forecast

25.123 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Orthopediatrics Corp (NASDAQ-KIDS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Orthopediatrics Corp (NASDAQ-KIDS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.69

No elevated caution signal from this screen.

Altman Z-Score

1.8

Intermediate risk zone.

FCF / Net Income

31.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Orthopediatrics Corp (NASDAQ-KIDS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Orthopediatrics Corp (NASDAQ-KIDS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Orthopediatrics Corp (NASDAQ-KIDS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Orthopediatrics Corp (NASDAQ-KIDS) Stock Forecast & Technical Outlook

Review Orthopediatrics Corp (NASDAQ-KIDS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Orthopediatrics Corp (NASDAQ-KIDS) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Orthopediatrics Corp (NASDAQ-KIDS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Orthopediatrics Corp (NASDAQ-KIDS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Orthopediatrics Corp (NASDAQ-KIDS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Orthopediatrics Corp (NASDAQ-KIDS) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Orthopediatrics Corp (NASDAQ-KIDS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Orthopediatrics Corp (NASDAQ-KIDS) has a Strong Buy consensus, with 5 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 5
Hold 1
Sell 0
FAQ Fast Investor Answers

Orthopediatrics Corp (NASDAQ-KIDS) Stock FAQ

Quick answers about Orthopediatrics Corp (NASDAQ-KIDS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$20.17
Estimated upside 3.5%
Valuation Rating
Undervalued
Estimated upside of 3.5%
Analyst Target
$25
Implied upside 28.2%
Financial Health
Good
Current financial-health read

The current fair value estimate for Orthopediatrics Corp (NASDAQ-KIDS) is $20.17. This implies an estimated upside of 3.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 3.5% versus the current market price.

The available analyst price target for Orthopediatrics Corp (NASDAQ-KIDS) is $25. The analyst target implies estimated upside of 28.2%.

The current financial health read for Orthopediatrics Corp (NASDAQ-KIDS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Orthopediatrics Corp (NASDAQ-KIDS) is August 5, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Orthopediatrics Corp (NASDAQ-KIDS) is -12.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Orthopediatrics Corp is 501.4 M.

The current enterprise value listed for Orthopediatrics Corp is 565 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Orthopediatrics Corp is NASDAQ-KIDS, and the stock is listed on NASDAQ.

Orthopediatrics Corp (NASDAQ-KIDS) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Orthopediatrics Corp is 18.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Orthopediatrics Corp is 66.5%. Free float helps investors understand how much of the share base is available for public trading.